Back

Effect of neprilysin inhibition on blood urea nitrogen creatinine ratio in HFrEF : comparison of the solvd and paradigm-hf trials

20 May 2023 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Heart failure with reduced ejection fraction (HFrEF) 1 Heart Failure with Reduced Ejection Fraction (HFrEF) HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Paolo Tolomeo

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Peak oxygen consumption measured by cardiopulmonary testing is associated with inotropic reserve in patients with heart failure with reduced ejection fraction
Mr S. Soulaidopoulos (Athens, GR)
Abstract Slides
Presentation thumbnail
Effect of stimulation frequency on left ventricular mechanical and electrical dyssynchrony in heart failure patients treated with cardiac resynchronization therapy
Doctor J. Naar (Prague, CZ)
Abstract Slides
Presentation thumbnail
18-month pattern of cardiac-specific biomarkers and replacement and interstitial fibrosis in dilated cardiomyopathy
Doctor S. Wisniowska-Smialek (Krakow, PL)
Abstract Slides
Presentation thumbnail
Combined neuro-humoral modulation and outcome in patients with chronic heart failure and mildly reduced or preserved ejection fraction
Doctor M. Gori (Bergamo, IT)
Abstract Slides
Presentation thumbnail
Treatment trajectory of Sacubitril/Valsartan initiation among >50,000 older adults with heart failure with reduced ejection fraction in the United States
Doctor A. Bhatt (San Francisco, US)
Abstract Slides

Access the full session

Session thumbnail
Heart failure with reduced ejection fraction (HFrEF) 1

The Event

Event poster

Heart Failure 2023

20 May - 23 May 2023
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Clinical characteristics and long-term prognosis of patients with heart failure with reduced, mildly reduced, and preserved left ventricular ejection fraction secondary to Chagas cardiomyopathy
thumbnail
Webinar
Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources